HIV-1 SUBTYPES IN POTENTIAL VACCINE TRIAL SITES OF THE WHO

被引：0
|
作者：
HERRING, BL
WASI, CP
DELWART, EL
MULLINS, JI
OSMANOV, S
机构：
[1] UNIV WASHINGTON,DEPT MICROBIOL,SEATTLE,WA 98195
[2] MAHIDOL UNIV,DEPT MICROBIOL,BANGKOK 10700,THAILAND
[3] AARON DIAMOND AIDS RES INST,NEW YORK,NY
[4] WHO,GLOBAL PROGRAMME AIDS,VACCINE DEV UNIT,CH-1211 GENEVA 27,SWITZERLAND
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1995年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：236 / 236
页数：1
相关论文
共 50 条
  • [1] Neutralization of HIV-1 subtypes: Implications for vaccine formulations
    Smith, TL
    van Rensburg, EJ
    Engelbrecht, S
    JOURNAL OF MEDICAL VIROLOGY, 1998, 56 (03) : 264 - 268
  • [2] Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvert
    Kim, HN
    Tabet, SR
    Corey, L
    Celum, CL
    VACCINE, 2006, 24 (04) : 532 - 539
  • [3] HIV-1 diversity in Brazil:: Genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites
    Bongertz, V
    Bou-Habib, DC
    Brígido, LFM
    Caseiro, M
    Chequer, PJN
    Couto-Fernandez, JC
    Ferreira, PC
    Galvao-Castro, B
    Greco, D
    Guimaraes, ML
    de Carvalho, MIL
    Morgado, MG
    Oliveira, CAF
    Osmanov, S
    Ramos, CA
    Rossini, M
    Sabino, E
    Tanuri, A
    Ueda, M
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (02) : 184 - 193
  • [4] First HIV-1 vaccine in phase III trial
    Morris, K
    LANCET, 1998, 351 (9118): : 1789 - 1789
  • [5] Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection
    Eron, JJ
    Ashby, MA
    Giordano, MF
    Chernow, M
    Reiter, WM
    Deeks, SG
    Lavelle, JP
    Conant, MA
    Yangco, BG
    Pate, PG
    Torres, RA
    Mitsuyasu, RT
    Twaddell, T
    LANCET, 1996, 348 (9041): : 1547 - 1551
  • [6] A novel HIV vaccine approach: targeting the protease cleavage sites of HIV-1
    Luo, M.
    Tang, D.
    Capina, R.
    Yuan, X. -Y.
    Prego, C.
    Pinto, J. C.
    Alonso, M.
    Barry, C.
    Pilon, R.
    Daniuk, C.
    Tuff, J.
    Pillet, S.
    La, D.
    Bielawny, T.
    Czarnecki, C.
    Lacap, P.
    Peters, H.
    Wong, G.
    Kimani, M.
    Wachihi, C.
    Kimani, J.
    Ball, T.
    Sandstrom, P.
    Kobinger, G.
    Plummer, F.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 29 - 30
  • [7] HIV-1 Tat protein as a potential AIDS vaccine
    Goldstein, G
    NATURE MEDICINE, 1996, 2 (09) : 960 - 964
  • [8] Antibody neutralization of HIV-1 and the potential for vaccine design
    Sattentau, QJ
    Moulard, M
    Brivet, B
    Botto, F
    Guillemot, JC
    Mondor, I
    Poignard, P
    Ugolini, S
    IMMUNOLOGY LETTERS, 1999, 66 (1-3) : 143 - 149
  • [9] HIV-1 subtypes in Yugoslavia
    Stanojevic, M
    Papa, A
    Papadimitriou, E
    Zerjav, S
    Jevtovic, D
    Salemovic, D
    Jovanovic, T
    Antoniadis, A
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (07) : 519 - 522
  • [10] GENETIC SUBTYPES OF HIV-1
    LOUWAGIE, J
    MCCUTCHAN, F
    MASCOLA, J
    EDDY, G
    FRANSEN, K
    PEETERS, M
    VANDERGROEN, G
    BURKE, D
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 : S147 - S150
12345